Your browser doesn't support javascript.
loading
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Haddad, R I; Massarelli, E; Lee, J J; Lin, H Y; Hutcheson, K; Lewis, J; Garden, A S; Blumenschein, G R; William, W N; Pharaon, R R; Tishler, R B; Glisson, B S; Pickering, C; Gold, K A; Johnson, F M; Rabinowits, G; Ginsberg, L E; Williams, M D; Myers, J; Kies, M S; Papadimitrakopoulou, V.
Affiliation
  • Haddad RI; Department of Medical Oncology, Dana Farber Cancer Institute, Boston.
  • Massarelli E; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston; Department of Medical Oncology and Therapeutics Research, City of Hope Cancer Center, Duarte.
  • Lee JJ; Departments of Biostatistics.
  • Lin HY; Departments of Biostatistics.
  • Hutcheson K; Head and Neck Surgery.
  • Lewis J; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
  • Garden AS; Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Blumenschein GR; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
  • William WN; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston; Oncology Center, Hospital BP, A Beneficencia Portuguesa de São Paulo, São Paulo, Brazil.
  • Pharaon RR; Department of Medical Oncology and Therapeutics Research, City of Hope Cancer Center, Duarte.
  • Tishler RB; Department of Radiation Oncology, Dana Farber Cancer Institute, Boston.
  • Glisson BS; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
  • Pickering C; Head and Neck Surgery.
  • Gold KA; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla.
  • Johnson FM; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
  • Rabinowits G; Department of Medical Oncology, Dana Farber Cancer Institute, Boston; Department of Head and Neck Oncology, Baptist Health South Florida, Coral Gables.
  • Ginsberg LE; Departments of Diagnostic Radiology.
  • Williams MD; Pathology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Myers J; Head and Neck Surgery.
  • Kies MS; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
  • Papadimitrakopoulou V; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. Electronic address: vpapadim@mdanderson.org.
Ann Oncol ; 30(3): 471-477, 2019 03 01.
Article in En | MEDLINE | ID: mdl-30596812
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / Papillomavirus Infections / Squamous Cell Carcinoma of Head and Neck / Neoplasm Recurrence, Local Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / Papillomavirus Infections / Squamous Cell Carcinoma of Head and Neck / Neoplasm Recurrence, Local Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication: Reino Unido